Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: UCB

Market Cap 52.33B 60.59B 48.22B 45.14B 84.59B 5,759B 85.9B 569B 222B 2,803B 227B 223B 9,706B P/E Ratio 2026 *
29.7x
P/E Ratio 2027 * 22.8x
Enterprise Value 51.21B 59.29B 47.19B 44.17B 82.78B 5,635B 84.06B 557B 217B 2,743B 223B 218B 9,497B EV / Sales 2026 *
6x
EV / Sales 2027 * 5.1x
Free-Float
61.59%
Yield 2026 *
0.53%
Yield 2027 * 0.55%
1 day+1.44%
1 week+5.33%
Current month+9.22%
1 month+14.97%
3 months+10.14%
6 months+16.83%
Current year+15.21%
1 week 255.4
Extreme 255.4
275.5
1 month 228.7
Extreme 228.7
275.5
Current year 223
Extreme 223
289.5
1 year 153.65
Extreme 153.65
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 31/12/2014
Director of Finance/CFO 59 30/06/2020
Chief Tech/Sci/R&D Officer 59 30/04/2024
Director TitleAgeSince
Director/Board Member 55 31/12/2011
Director/Board Member 67 31/12/2014
Director/Board Member 56 23/04/2014
Date Insider Type Main position Quantity % Market Cap.
01-14Fiscal year

Executive/Senior Manager

3,000 0.0015%
01-14Buy

Director

500 0.0003%
01-14Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.44%+5.33%+68.19%+222.27% 60.59B
+0.11%-3.67%+15.66%-20.23% 62.28B
+0.70%+29.50%+29.50%+29.50% 39.55B
+0.26%+9.80%-54.99%-65.15% 36.8B
+0.05%+2.41%+53.12%-34.32% 29.53B
+0.65%+6.01%+60.19%+75.19% 21.68B
+0.54%+5.21%+87.14%-61.00% 19.8B
+4.80%-0.20%-5.27%+115.05% 16.96B
+0.18%-1.66%+54.11%+100.91% 16.16B
+0.55%+9.84%+145.12%+240.77% 13.13B
Average +0.93%+3.78%+45.28%+60.30% 31.65B
Weighted average by Cap. +0.79%+3.27%+36.46%+54.12%

Financials

2026 *2027 *
Net sales 8.53B 9.88B 7.86B 7.36B 13.79B 939B 14B 92.81B 36.19B 457B 37.06B 36.28B 1,582B 9.65B 11.17B 8.89B 8.32B 15.59B 1,062B 15.84B 105B 40.92B 517B 41.92B 41.02B 1,789B
Net income 1.76B 2.03B 1.62B 1.52B 2.84B 193B 2.88B 19.12B 7.45B 94.11B 7.63B 7.47B 326B 2.28B 2.64B 2.1B 1.97B 3.69B 251B 3.74B 24.82B 9.68B 122B 9.91B 9.7B 423B
Net Debt -1.12B -1.3B -1.03B -969M -1.82B -124B -1.84B -12.22B -4.76B -60.16B -4.88B -4.78B -208B -3.1B -3.59B -2.86B -2.68B -5.02B -341B -5.09B -33.76B -13.16B -166B -13.48B -13.2B -576B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
12/06/26 274.90 +1.44% 169,042
11/06/26 271.00 +2.50% 172,437
10/06/26 264.40 +0.80% 154,966
09/06/26 262.30 +0.50% 181,814
08/06/26 261.00 0.00% 186,819
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
274.90EUR
Average target price
289.47EUR
Spread / Average Target
+5.30%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!